CRANBURY, N.J.; Jan. 24, 2023 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, today announced the expansion of its analytical laboratory and services. The new laboratory is …
News
Experic Closes $14 Million Series B Financing
CRANBURY, N.J.; November 30, 2022 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, today announced the closing of a $14 million series B capitalization led by Harro Höfliger Packaging …
CONSTRUCTING A PHARMA DEVELOPMENT & MANUFACTURING PROJECT PLAN: STEPS TO EVALUATE RISK & FIND EFFICIENCIES, UPCOMING WEBINAR HOSTED BY XTALKS
TORONTO (PRWEB) NOVEMBER 10, 2022 – There are a variety of reasons why companies want to accelerate pharma development & manufacturing timelines: to produce drug products for a clinical trial, make products for compassionate use, or meet a management commitment to serve patients, etc. While the …
Experic Appoints Derek Hennecke to Its Board of Directors
CRANBURY, N.J., Sept. 20, 2022 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the pharmaceutical industry, today announced the appointment of Derek Hennecke as an independent member of its board of …
Combination Drug Products: What Lies Beneath – Risk Analysis for Product Development, Upcoming Webinar Hosted by Xtalks
TORONTO – OCTOBER 12, 2021 – A robust approach for combination drug product development requires an understanding of the drug product characteristics, the effects of processing and device design and how they impact product performance. Risk management connects the dots and interactions of these …
